Patent 7662566 was granted and assigned to Myriad Genetics on February, 2010 by the United States Patent and Trademark Office.
The invention relates to copy number profile analysis. Specifically, copy number profile analysis is used to determine whether two or more separate tumors in a single individual are derived from a common source.